share_log

Stifel Maintains Buy on DarioHealth, Lowers Price Target to $6

Benzinga ·  Jul 25, 2023 19:27

Stifel analyst David Grossman maintains DarioHealth (NASDAQ:DRIO) with a Buy and lowers the price target from $9 to $6.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment